Katrina H. Smith

690 total citations
12 papers, 266 citations indexed

About

Katrina H. Smith is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Katrina H. Smith has authored 12 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Katrina H. Smith's work include Glioma Diagnosis and Treatment (10 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Katrina H. Smith is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Katrina H. Smith collaborates with scholars based in United States. Katrina H. Smith's co-authors include David A. Reardon, Andrew D. Norden, Sarah Gaffey, Alona Muzikansky, Christine McCluskey, Tracy T. Batchelor, Jeffrey J. Raizer, Mikael L. Rinne, Sean Grimm and A. S. and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Neuro-Oncology.

In The Last Decade

Katrina H. Smith

12 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katrina H. Smith United States	5	93	92	78	67	48	12	266
Faye Robertson United Kingdom	6	75 0.8×	65 0.7×	52 0.7×	96 1.4×	23 0.5×	7	259
Isabelle Pommepuy France	11	94 1.0×	75 0.8×	40 0.5×	45 0.7×	52 1.1×	23	312
Chin-Kan Chan Taiwan	7	236 2.5×	52 0.6×	81 1.0×	33 0.5×	61 1.3×	8	287
Baoxun Li China	3	225 2.4×	47 0.5×	70 0.9×	64 1.0×	38 0.8×	3	301
Christian Binet France	12	75 0.8×	110 1.2×	28 0.4×	94 1.4×	22 0.5×	22	355
Н. А. Петинати Russia	9	203 2.2×	58 0.6×	60 0.8×	44 0.7×	19 0.4×	51	274
R. Lopa Italy	8	83 0.9×	102 1.1×	38 0.5×	51 0.8×	20 0.4×	14	218
Matthäus Felsenstein Germany	10	41 0.4×	74 0.8×	98 1.3×	215 3.2×	52 1.1×	30	329
France Bruck Belgium	4	154 1.7×	34 0.4×	48 0.6×	55 0.8×	33 0.7×	5	258
Rekha Chaudhary United States	8	78 0.8×	88 1.0×	23 0.3×	58 0.9×	79 1.6×	27	283

Countries citing papers authored by Katrina H. Smith

Since Specialization

Citations

This map shows the geographic impact of Katrina H. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina H. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina H. Smith more than expected).

Fields of papers citing papers by Katrina H. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina H. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina H. Smith. The network helps show where Katrina H. Smith may publish in the future.

Co-authorship network of co-authors of Katrina H. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina H. Smith. A scholar is included among the top collaborators of Katrina H. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina H. Smith. Katrina H. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lee, Eudocia Q., Dan G. Duda, Alona Muzikansky, et al.. (2018). Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma. Clinical Cancer Research. 24(19). 4643–4649. 49 indexed citations

Lee, E. Q., David A. Reardon, D. Schiff, et al.. (2015). Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma. Neuro-Oncology. 17(6). 862–867. 103 indexed citations

Lee, Eudocia Q., Alona Muzikansky, Elizabeth R. Gerstner, et al.. (2015). Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.. Journal of Clinical Oncology. 33(15_suppl). TPS2080–TPS2080. 2 indexed citations

Norden, Andrew D., Jan Drappatz, Surasak Phuphanich, et al.. (2014). Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma: Final results.. Journal of Clinical Oncology. 32(15_suppl). 2027–2027. 1 indexed citations

Smith, Katrina H., Eudocia Q. Lee, Alona Muzikansky, et al.. (2014). Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.. Journal of Clinical Oncology. 32(15_suppl). 2031–2031. 1 indexed citations

Norden, Andrew D., David Schiff, Manmeet S. Ahluwalia, et al.. (2014). Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas: Final results.. Journal of Clinical Oncology. 32(15_suppl). 2053–2053. 1 indexed citations

Lee, Eudocia Q., Alona Muzikansky, Santosh Kesari, et al.. (2014). A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.. Journal of Clinical Oncology. 32(15_suppl). 2004–2004. 4 indexed citations

Lee, Eudocia Q., David A. Reardon, David Schiff, et al.. (2014). Panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.. Journal of Clinical Oncology. 32(15_suppl). 2020–2020. 3 indexed citations

Lee, Eudocia Q., David A. Reardon, David Schiff, et al.. (2013). Interim analysis of a phase I/II study of panobinostat in combination with bevacizumab for recurrent glioblastoma.. Journal of Clinical Oncology. 31(15_suppl). 2013–2013. 21 indexed citations

10.

Norden, Andrew D., David Schiff, Manmeet S. Ahluwalia, et al.. (2013). Phase II trial of triple-receptor tyrosine kinase receptor inhibitor nintedanib (BIBF 1120) in recurrent high-grade gliomas.. Journal of Clinical Oncology. 31(15_suppl). TPS2104–TPS2104. 2 indexed citations

11.

Wille, Keith, Amit Gaggar, Kevin León, et al.. (2008). Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis.. PubMed. 25(2). 117–24. 13 indexed citations

12.

Pinderski, Laura J., James K. Kirklin, David C. McGiffin, et al.. (2005). Multi-organ Transplantation: Is There a Protective Effect Against Acute and Chronic Rejection?. The Journal of Heart and Lung Transplantation. 24(11). 1828–1833. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact